Evidence map›Paper›PMID 34208000›Full record

ArticleBioengineering (Basel, Switzerland)2021

Analysis and Forecasting Incidence, Intensive Care Unit Admissions, and Projected Mortality Attributable to COVID-19 in Portugal, the UK, Germany, Italy, and France: Predictions for 4 Weeks Ahead.

Kathleen Carvalho, João Paulo Vicente, Mihajlo Jakovljevic, João Paulo Ramos Teixeira

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathleen CarvalhoResearch Centre in Digitalization and Intelligent Robotics (CeDRI)-Instituto Politecnico de Braganca, 5300-253 Bragança, Portugal.
João Paulo VicenteResearch Centre in Digitalization and Intelligent Robotics (CeDRI)-Instituto Politecnico de Braganca, 5300-253 Bragança, Portugal.
Mihajlo JakovljevicDepartment of Global Health Economics and Policy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-9160-6846
João Paulo Ramos TeixeiraResearch Centre in Digitalization and Intelligent Robotics (CeDRI)-Instituto Politecnico de Braganca, 5300-253 Bragança, Portugal.ORCID 0000-0002-6679-5702

Funding

Fundação para a Ciência e a Tecnologia UIDB/05757/2020
6 · The paper itself

Abstract

The use of artificial neural networks (ANNs) is a great contribution to medical studies since the application of forecasting concepts allows for the analysis of future diseases propagation. In this context, this paper presents a study of the new coronavirus SARS-COV-2 with a focus on verifying the virus propagation associated with mitigation procedures and massive vaccination campaigns. There were two proposed methodologies in making predictions 28 days ahead for the number of new cases, deaths, and ICU patients of five European countries: Portugal, France, Italy, the United Kingdom, and Germany. A case study of the results of massive immunization in Israel was also considered. The data input of cases, deaths, and daily ICU patients was normalized to reduce discrepant numbers due to the countries' size and the cumulative vaccination values by the percentage of population immunized (with at least one dose of the vaccine). As a comparative criterion, the calculation of the mean absolute error (MAE) of all predictions presents the best methodology, targeting other possibilities of use for the method proposed. The best architecture achieved a general MAE for the 1-to-28-day ahead forecast, which is lower than 30 cases, 0.6 deaths, and 2.5 ICU patients per million people.

Indexed as

ANN forecastingCOVID-19 in EuropeCOVID-19 in IsraelCOVID-19 prediction casesCOVID-19 prediction deathsCOVID-19 prediction ICUCOVID-19 vaccinationCOVID-19 wearing of face masknew coronavirustime series prediction

Identifiers

PMID34208000
PMCPMC8230711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.